Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1990 Nov:26 Suppl C:71-5.
doi: 10.1093/jac/26.suppl_c.71.

Pharmacokinetics of cefodizime in the elderly following single and repeated intravenous administration of 1 g

Affiliations
Clinical Trial

Pharmacokinetics of cefodizime in the elderly following single and repeated intravenous administration of 1 g

O G Nilsen et al. J Antimicrob Chemother. 1990 Nov.

Abstract

In an open, crossover study of 12 patients of mean age 74 (range 64-88) who required perioperative prophylactic antibiotic therapy, cefodizime was administered as a single iv infusion of 1 g, and repeated infusions of 1 g twice daily for 4.5 days. Serum and urine concentrations of cefodizime were determined by high performance liquid chromatography. The following pharmacokinetic indices were estimated after single and repeated (values in brackets) dosing: C0.15h 269 (285) mg/l; C12h 8.7 (8.5) mg/l; AUC 557 (494) mg.h/l; Clt 1.93 (2.20) l/h; Vdss 8.62 (8.56) l; T1-2 4.06 (4.07) h; U0-36h: 569 (624) mg; and Clr0-12h 1.17 (1.39) l/h. No statistically significant differences in these values were found between single and repeated dose treatments. These results demonstrate a lack of accumulation and no changes in the pharmacokinetic profile of cefodizime during repeated dosing in the elderly. No modification of the dosage regimen of cefodizime would appear to be necessary in the elderly as compared with young healthy subjects.

PubMed Disclaimer

Similar articles

Cited by

Publication types

LinkOut - more resources